Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: A 15-year follow-up of NIPPON DATA90

Atherosclerosis

Volumn 215, Issue 1, 2011, Pages 209-213

  Kadota, Aya ^a   Miura, Katsuyuki ^a   Okamura, Tomonori ^b   Hozawa, Atsushi ^c   Murakami, Yoshitaka ^a   Fujiyoshi, Akira ^a   Takashima, Naoyuki ^a   Hayakawa, Takehito ^d   Kita, Yoshikuni ^a   Okayama, Akira ^e   Nakamura, Yasuyuki ^f   Ueshima, Hirotsugu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e FUKUJUJI HOSPITAL   (Japan)

^f KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Epidemiology; Metabolic risk factor; Mortality

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; THINNESS;

EID: 79952102381     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.033     Document Type: Article

References (31)

1. Reaven G.M. Banting lecture role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
2. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514-1520.
3. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
4. Fujioka S., Matsuzawa Y., Tokunaga K., et al. Contribution of intra-abdominal visceral fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
5. McNeil A.M., Rosamond W.D., Girman C., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005, 28:385-390.
6. Katzmarzyk P.T., Church T.S., Blair S.N. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 2004, 164:1092-1097.
7. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 2005, 28:1769-1778.
8. Kadota A., Hozawa A., Okamura T., et al. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 2007, 30:1533-1538.
9. Iso H., Sato S., Kitamura A., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007, 38:1744-1751.
10. Ninomiya T., Kubo M., Doi Y., et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population. The Hisayama Study. Stroke 2007, 2063-2069.
11. Kokubo Y., Okamura T., Yoshimasa Y., et al. Impact of metabolic syndrome components of the incidence of cardiovascular disease in a general urban Japanese population: the Suita study. Hypertens Res 2008, 31:2027-2035.
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
13. Alberti K.G., Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
14. Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
15. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992.
16. Grundy S.M., Cleeman J.I., Merz N.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004, 110:227-239.
17. Gundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
18. NIPPON DATA80 Research Group Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006, 70:1249-1255.
19. NIPPON DATA80 Research Group Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese-NIPPON DATA80. J Hum Hypertens 2003, 17:851-857.
20. Okamura T., Tanaka H., Miyamatsu N., et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007, 190:216-223.
21. Oki I., Nakamura Y., Okamura T., et al. Body mass index and risk of stroke mortality among a random sample of Japanese adults: 19-year follow-up of NIPPON DATA80. Cerebrovasc Dis 2006, 22:404-415.
22. Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120.
23. Okamura T., Hayakawa T., Kadowaki T., et al. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004, 147:1024-1032.
24. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 29:S43-S48.
25. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee of Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003, 289:2560-2572.
26. Greenland S. Re: Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1999, 149:884.
27. Kannel W.B., Vasan R.S., Levy D. Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values?. Hypertension 2003, 42:453-456.
28. Khaw K.T., Wareham N., Bingham S., et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004, 141:413-420.
29. Vasan R.S., Sullivan L.M., Wilson P.W.F., et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 2005, 142:393-402.
30. Khot U.N., Khot M.B., Bajzaer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003, 290:898-904.
31. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003, 290:891-897.